Alec Stranahan
Stock Analyst at B of A Securities
(0.86)
# 2262
Out of 5,358 analysts
32
Total ratings
31.58%
Success rate
16.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Upgrades: Buy | 42 42 | 18.55 | 126.42% | 1 | Mar 28, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Neutral | 14 12 | 5.25 | 128.57% | 5 | Mar 5, 2025 | |
CADL Candel Therapeutics | Initiates Coverage On: Buy | 15 | 6.04 | 148.34% | 1 | Feb 7, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 28 25 | 7.17 | 248.68% | 4 | Jan 7, 2025 | |
CRBU Caribou Biosciences | Maintains: Buy | 13 11 | 1.25 | 780% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 5 | 1.6 | 212.5% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 6 | 3.33 | 80.18% | 2 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 13 15 | 1.92 | 681.25% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 41.1 | 33.82% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 7.45 | 141.61% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 136.78 | 2.35% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 9.65 | 335.23% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 40.04 | -85.01% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 1.56 | 220.51% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 46.8 | -3.85% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |